Intelligent Pharma wins the award CaràcterEmpresa to Innovation in Catalonia Blog Post

Intelligent Pharma, a company based at the Barcelona Science Park  (PCB), has won the Premi CaràcterEmpresa award in the category of Innovation among 14 companies from around Catalonia and has been selected to take part in the nation-wide final phase, that will take place this coming June. The CaràcterEmpresa awards are promoted by CaixaBank and by the Spanish Confederatiion of Business Organizations (CEOE) in the Catalan edition, also promoted by Foment del Treball, the institution representing the interests of Catalan industry and business.

Cebiotex opens a second crowdfunding round for the development of nanofiber tissues against cancer Blog Post

After having succesfully closed a first crowfunding round of 300,000 euros in just 11 days, Cebiotex, a spin-off of the Universitat Politècnica de Catalunya (UPC) and the Sant Joan de Déu-Barcelona Children’s Hospital, located at the Barcelona Science Park (PCB), has launched a second round of  300,000 euros, managed, once more, by European biotech crowdfunding platform CapitalCell. The company will allocate the resources obtained to expedite the development of an innovative system to administer antitumor drugs – a biodegradable nanofiber tissue for the local treatment of cancer- while ensuring that these new drugs are made available not only for adult patients but also for pediatric oncological patients 

 

How tissue stiffness activates cancer Blog Post

Researchers at IBEC and their collaborators at the Georgia Institute of Technology  (Georgia Tech), publishing today in Nature Cell Biology, have identified the mechanism by which tissue stiffness activates a protein called YAP, a major oncogene. The new knowledge could potentially lead to new strategies to impair or even halt the growth of tumours.

 

STAT-Diagnostica closes a round of investment worth 25 million euros Blog Post

Medical diagnostics company  STAT-Diagnostica, located at the Barcelona Science Park (PCB), has closed a Series C financing round totaling 25 million Euros/28.5 million USD. The proceeds will be used to prepare for the 2017 European launch of its DiagCORE Near Patient Testing system. Led by new investor Gilde Healthcare, the financing round also drew participation from existing investors, including Kurma Partners, Ysios Capital, Idinvest Partners, Boehringer Ingelheim Venture Fund, Caixa Capital Risc and Axis.

 

Identification of a new protein essential for ovule and sperm formation Blog Post

Scientists at he Institute for Research in Biomedicine (IRB Barcelona) –headed by ICREA researcher Angel R. Nebreda– discover a crucial protein for meiosis, the cell division process that gives rise to sex cells. Without the RingoA protein, both male and female mice are sterile. Published in Nature Communications, the results could pave the way for the development of male contraceptives.

 

More than 300 scientists gathered together in Barcelona at the IX Conference of Technological Platforms Blog Post

The Spanish Nanomedicine Platform (NanomedSpain), led by IBEC director Josep Samitier, is once again participating in the annual conference of IX Annual Conference of Biomedical Research Technological Platforms: Innovative Medicines, Nanomedicines, Healthcare Technology and Biotechnological markets. This event, which brings together around 300 scientists and researchers, has earned its place as a reference in biomedical research, since it allows the diffusion of the most recent national and international initiatives in public-private collaboration in this area.